ERIN MARTIN: Open Payments
NPI 1710451810 · COLUMBIA, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$392 in 14 payments from 9 companies in 2025. Trend: 2023 $622 · 2024 $584 · 2025 $392
Food & beverage: $392
| Company | Payments | Amount |
|---|---|---|
| Arcutis Biotherapeutics, Inc. | 1 | $113 |
| ABBVIE INC. | 5 | $91 |
| Novartis Pharmaceuticals Corporation | 2 | $54 |
| Regeneron Healthcare Solutions, Inc. | 1 | $29 |
| Amgen Inc. | 1 | $27 |
| PFIZER INC. | 1 | $23 |
| Botanix SB Inc | 1 | $21 |
| E.R. Squibb & Sons, L.L.C. | 1 | $17 |
| Incyte Corporation | 1 | $16 |
Products named: SKYRIZI, COSENTYX, DUPIXENT, OTEZLA, Rhapsido, CIBINQO, SOFDRA, Sotyktu.
Industry payments across MO — which companies pay providers there.
